AKT1 and plasma cell myeloma: In summary, here we identified a novel functional mechanism by which PIWIL1 confers chemotherapeutic drug resistance by activating mitophagy and the myeloma stem cell population through AKT-mTOR and PARKIN-dependent mitophagy pathways.